Is Invesco Ltd (IVZ) positioned for future growth?

With 5.29 million shares changed hands, the volume of the stock remained heavier than its average volume of 3.91 million shares. During the session, the Asset Management company that operates in wider Financial sector, reached to the highest price of $17.975 whereas the lowest price it dropped to was $17.185. The 52-week range on IVZ shows that it touched its highest point at $18.79 and its lowest point at $12.48 during that stretch. It currently has a 1-year price target of $19.06. With its current market cap of 7.88 billion, IVZ has annualized dividend of $0.81 while the current yield stands at 4.63%. IVZ paid its most recent dividend on 1723766400, while the ex-dividend date for that was 1731542400. Beta for the stock currently stands at 1.43.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of IVZ was down-trending over the past week, with a drop of -3.69%, but this was down by -0.28% over a month. Three-month performance surged to 2.28% while six-month performance rose 20.52%. The stock gained 39.78% in the past year, while it has lost -1.91% so far this year. A look at the trailing 12-month EPS for IVZ yields -0.92 with Next year EPS estimates of 1.89. For the next quarter, that number is 0.48. This implies an EPS growth rate of 10.80% for this year and 12.86% for next year.

Float and Shares Shorts:

At present, 449.50 million IVZ shares are outstanding with a float of 442.43 million shares on hand for trading. On 2024-09-30, short shares totaled 6.49 million, which was 144.00001 higher than short shares on 1724976000. In addition to Mr. Andrew Ryan Schlossberg as the firm’s President, CEO & Director, Ms. Laura Allison Dukes serves as its Senior MD & CFO.

Institutional Ownership:

Through their ownership of 0.89131 of IVZ’s outstanding shares, institutional investors have minority control over the company.

An Overview of Recent Financials:

Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2024-09-30, IVZ reported revenue of $1483300000.0 and operating income of $206800000.0. The EBITDA in the recently reported quarter was $322600000.0 and diluted EPS was $0.29.